BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Yang K, Meng X, Tian T, Fan P, Zhang H, Ma W, Song L, Wu H, Cai J, Luo F, Zhou X, Zheng D, Liu L. Cardiac Valve Involvement in Takayasu Arteritis Is Common: A Retrospective Study of 1,069 Patients Over 25 Years. Am J Med Sci 2018;356:357-64. [PMID: 30360804 DOI: 10.1016/j.amjms.2018.06.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Sener S, Arslanoglu Aydin E, Batu ED. Cardiac involvement and cardiovascular risk factors in pediatric primary systemic vasculitides. Clin Rheumatol 2022. [DOI: 10.1007/s10067-022-06434-2] [Reference Citation Analysis]
2 Wang Y, Ma L, Sun Y, Yu W, Wu S, Chen H, Dai X, Ma L, Jiang L. Risk factors of aortic regurgitation progression in Chinese patients with Takayasu's arteritis: a prospective cohort study. Ther Adv Chronic Dis 2022;13:20406223221127237. [PMID: 36213170 DOI: 10.1177/20406223221127237] [Reference Citation Analysis]
3 Fu J, Liu J, Li X, Wu S, Yu H, Zhang C. Role of Echocardiography in the Assessment of Cardiac Involvement in Takayasu Arteritis.. [DOI: 10.21203/rs.3.rs-1687264/v3] [Reference Citation Analysis]
4 Huo J, Wang B, Yu L, Gao D, Cheng R, Wang J, Zhou X, Tian T, Gao L. Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.948124] [Reference Citation Analysis]
5 Soto ME, Saucedo-Orozco H, Ochoa-Hein E, Eid-Lidt G, Anaya-Ayala JE, Pérez-Torres I, Koretzky SG, Reyes PA, Espinoza-Saquicela ER, Hernandez I, Martinez-Hernandez H. Cardiothoracic surgery and peripheral endovascular intervention in cardiovascular damage from a cohort of orphan rheumatological diseases-epidemiological and survival analysis. J Thorac Dis 2022;14:1815-29. [PMID: 35813724 DOI: 10.21037/jtd-21-1523] [Reference Citation Analysis]
6 Shi X, Du J, Li T, Gao N, Fang W, Chen S, Qiao Z, Li C, Zhu J, Pan L. Risk factors and surgical prognosis in patients with aortic valve involvement caused by Takayasu arteritis. Arthritis Res Ther 2022;24:102. [PMID: 35526024 DOI: 10.1186/s13075-022-02788-9] [Reference Citation Analysis]
7 Regola F, Uzzo M, Toniati P, Trezzi B, Sinico RA, Franceschini F. Novel Therapies in Takayasu Arteritis. Front Med (Lausanne) 2021;8:814075. [PMID: 35096902 DOI: 10.3389/fmed.2021.814075] [Reference Citation Analysis]
8 Zhou Y, Feng Y, Zhang W, Li H, Zhang K, Wu Z. Physical Exercise in Managing Takayasu Arteritis Patients Complicated With Cardiovascular Diseases. Front Cardiovasc Med 2021;8:603354. [PMID: 34055922 DOI: 10.3389/fcvm.2021.603354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ignatenko GA, Vatutin NT, Taradin GG, Shevelok AN, Rakitskaya IV. Aortic regurgitation: epidemiologic, etiologic, and pathophysiologic characteristics. Klinicist 2021;14:57-68. [DOI: 10.17650/1818-8338-2020-14-3-4-k639] [Reference Citation Analysis]
10 Alibaz-oner F, Direskeneli H. Clinical Manifestations, Differential Diagnosis, and Laboratory Markers. Large and Medium Size Vessel and Single Organ Vasculitis 2021. [DOI: 10.1007/978-3-030-67175-4_9] [Reference Citation Analysis]
11 Zhang Y, Fan P, Zhang H, Ma W, Song L, Wu H, Cai J, Luo F, Zhou X. Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients. Int J Cardiol 2021;325:103-8. [PMID: 33086124 DOI: 10.1016/j.ijcard.2020.10.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Koster MJ, Warrington KJ, Matteson EL. Morbidity and Mortality of Large-Vessel Vasculitides. Curr Rheumatol Rep 2020;22. [DOI: 10.1007/s11926-020-00963-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Pazzola G, Pipitone N, Salvarani C. Cardiac involvement in the adult primary vasculitides. Expert Rev Clin Immunol 2020;16:985-91. [PMID: 32954889 DOI: 10.1080/1744666X.2021.1823219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Silveira LH. Cardiovascular Manifestations of Systemic Vasculitides. Curr Rheumatol Rep 2020;22. [DOI: 10.1007/s11926-020-00952-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Soulaidopoulos S, Madenidou A, Daoussis D, Melissaropoulos K, Mavrogeni S, Kitas G, Dimitroulas T. Cardiovascular Disease in the Systemic Vasculitides. CVP 2020;18:463-72. [DOI: 10.2174/1570161118666200130093432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Pan L, Du J, Zhu J, Qiao Z, Ren Y, Huang X, Guo S, Gao N. Elevated antistreptolysin O titer is closely related to cardiac mitral insufficiency in untreated patients with Takayasu arteritis. BMC Cardiovasc Disord 2020;20:52. [PMID: 32013899 DOI: 10.1186/s12872-020-01364-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zhang Y, Fan P, Zhang H, Ma W, Song L, Wu H, Cai J, Zhou X. Surgical Treatment in Patients With Aortic Regurgitation Due to Takayasu Arteritis. Ann Thorac Surg 2020;110:165-71. [PMID: 31756318 DOI: 10.1016/j.athoracsur.2019.10.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Meng X, Zhou Y, Jiang XJ, Cai J, Zhang HM, Wu HY, Ma WJ, Lou Y, Liu YX, Zhou XL. Etiology spectrum and clinical characteristics of renal artery stenosis in a Chinese cohort. J Geriatr Cardiol 2021;18:104-13. [PMID: 33747059 DOI: 10.11909/j.issn.1671-5411.2021.02.001] [Reference Citation Analysis]